ALPHATEC HOLDINGS INC (ATEC)

US02081G2012 - Common Stock

9.37  0 (0%)

After market: 9.37 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ATEC. ATEC was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ATEC have multiple concerns. ATEC is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

ATEC had negative earnings in the past year.
In the past year ATEC has reported a negative cash flow from operations.
ATEC had negative earnings in each of the past 5 years.
In the past 5 years ATEC always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of ATEC (-23.85%) is comparable to the rest of the industry.
With a Return On Equity value of -799.73%, ATEC is not doing good in the industry: 89.25% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -23.85%
ROE -799.73%
ROIC N/A
ROA(3y)-25.87%
ROA(5y)-28.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ATEC has a Gross Margin of 69.47%. This is amongst the best in the industry. ATEC outperforms 80.11% of its industry peers.
ATEC's Gross Margin has been stable in the last couple of years.
ATEC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.37%

More info and screens

2

2. Health

2.1 Basic Checks

ATEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATEC has more shares outstanding
The number of shares outstanding for ATEC has been increased compared to 5 years ago.
The debt/assets ratio for ATEC has been reduced compared to a year ago.

2.2 Solvency

ATEC has an Altman-Z score of -0.75. This is a bad value and indicates that ATEC is not financially healthy and even has some risk of bankruptcy.
ATEC has a worse Altman-Z score (-0.75) than 60.75% of its industry peers.
A Debt/Equity ratio of 23.65 is on the high side and indicates that ATEC has dependencies on debt financing.
With a Debt to Equity ratio value of 23.65, ATEC is not doing good in the industry: 90.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 23.65
Debt/FCF N/A
Altman-Z -0.75
ROIC/WACCN/A
WACC8.53%

2.3 Liquidity

ATEC has a Current Ratio of 2.32. This indicates that ATEC is financially healthy and has no problem in meeting its short term obligations.
ATEC has a Current ratio of 2.32. This is comparable to the rest of the industry: ATEC outperforms 40.86% of its industry peers.
A Quick Ratio of 1.15 indicates that ATEC should not have too much problems paying its short term obligations.
ATEC has a worse Quick ratio (1.15) than 69.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.15

More info and screens

6

3. Growth

3.1 Past

ATEC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.23%, which is quite good.
Looking at the last year, ATEC shows a very strong growth in Revenue. The Revenue has grown by 27.22%.
ATEC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.37% yearly.
EPS 1Y (TTM)15.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)27.22%
Revenue growth 3Y49.3%
Revenue growth 5Y39.37%
Sales Q2Q%27.44%

3.2 Future

ATEC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.99% yearly.
Based on estimates for the next years, ATEC will show a quite strong growth in Revenue. The Revenue will grow by 19.01% on average per year.
EPS Next Y27.95%
EPS Next 2Y25.21%
EPS Next 3Y21.12%
EPS Next 5Y24.99%
Revenue Next Year27.38%
Revenue Next 2Y23.95%
Revenue Next 3Y22.2%
Revenue Next 5Y19.01%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATEC. In the last year negative earnings were reported.
Also next year ATEC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ATEC's earnings are expected to grow with 21.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.21%
EPS Next 3Y21.12%

More info and screens

0

5. Dividend

5.1 Amount

ATEC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHATEC HOLDINGS INC

NASDAQ:ATEC (1/6/2025, 4:01:33 PM)

After market: 9.37 0 (0%)

9.37

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners67.02%
Inst Owner Change0%
Ins Owners9.69%
Ins Owner Change0.7%
Market Cap1.33B
Analysts82.22
Price Target17.21 (83.67%)
Short Float %10.39%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.39%
Min EPS beat(2)-9.49%
Max EPS beat(2)-3.28%
EPS beat(4)0
Avg EPS beat(4)-15.93%
Min EPS beat(4)-44.19%
Max EPS beat(4)-3.28%
EPS beat(8)0
Avg EPS beat(8)-21.8%
EPS beat(12)0
Avg EPS beat(12)-22.98%
EPS beat(16)0
Avg EPS beat(16)-31.56%
Revenue beat(2)1
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)0.37%
Revenue beat(4)3
Avg Revenue beat(4)0.92%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)3.25%
Revenue beat(8)7
Avg Revenue beat(8)1.92%
Revenue beat(12)11
Avg Revenue beat(12)3.16%
Revenue beat(16)14
Avg Revenue beat(16)4.56%
PT rev (1m)0.25%
PT rev (3m)-3.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.46%
EPS NY rev (1m)-0.92%
EPS NY rev (3m)-3.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.32
P/FCF N/A
P/OCF N/A
P/B 59.73
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.28
EYN/A
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS4.04
BVpS0.16
TBVpS-1.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.85%
ROE -799.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.47%
FCFM N/A
ROA(3y)-25.87%
ROA(5y)-28.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.37%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 23.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 158.01%
Cap/Sales 20.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.32
Quick Ratio 1.15
Altman-Z -0.75
F-Score6
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)174.56%
Cap/Depr(5y)177.6%
Cap/Sales(3y)20.94%
Cap/Sales(5y)18.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y27.95%
EPS Next 2Y25.21%
EPS Next 3Y21.12%
EPS Next 5Y24.99%
Revenue 1Y (TTM)27.22%
Revenue growth 3Y49.3%
Revenue growth 5Y39.37%
Sales Q2Q%27.44%
Revenue Next Year27.38%
Revenue Next 2Y23.95%
Revenue Next 3Y22.2%
Revenue Next 5Y19.01%
EBIT growth 1Y2.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.4%
EBIT Next 3Y40.7%
EBIT Next 5Y27.04%
FCF growth 1Y-36.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.72%
OCF growth 3YN/A
OCF growth 5YN/A